Total Payments
$1.3M
2022 Payments
$97,013
Companies
60
Transactions
2,337
Medicare Patients
2,502
Medicare Billing
$249,907
Payment Breakdown by Category
Other$1.0M (81.2%)
Travel$77,731 (6.1%)
Consulting$68,071 (5.4%)
Research$54,726 (4.3%)
Food & Beverage$36,692 (2.9%)
Education$558.72 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.0M | 530 | 81.2% |
| Travel and Lodging | $77,731 | 387 | 6.1% |
| Consulting Fee | $68,071 | 27 | 5.4% |
| Unspecified | $54,726 | 2 | 4.3% |
| Food and Beverage | $36,692 | 1,380 | 2.9% |
| Education | $558.72 | 11 | 0.0% |
Payments by Type
General
$1.2M
2,335 transactions
Research
$54,726
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $349,930 | 514 | $0 (2022) |
| GENZYME CORPORATION | $330,774 | 406 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $124,142 | 155 | $0 (2021) |
| Biogen, Inc. | $105,178 | 163 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $70,644 | 175 | $0 (2022) |
| Genentech USA, Inc. | $59,502 | 115 | $0 (2022) |
| Eli Lilly and Company | $54,726 | 2 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $49,135 | 196 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $38,502 | 50 | $0 (2022) |
| Lilly USA, LLC | $35,153 | 94 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $97,013 | 218 | Biohaven Pharmaceutical Holding Company Ltd. ($38,502) |
| 2021 | $249,707 | 465 | Biohaven Pharmaceuticals, Inc. ($108,529) |
| 2020 | $132,938 | 293 | Amgen Inc. ($44,032) |
| 2019 | $283,737 | 476 | GENZYME CORPORATION ($100,941) |
| 2018 | $350,078 | 580 | Amgen Inc. ($129,955) |
| 2017 | $150,983 | 305 | GENZYME CORPORATION ($83,641) |
All Payment Transactions
2,337 individual payment records from CMS Open Payments — Page 1 of 94
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/15/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: Neuroscience | ||||||
| 06/07/2022 | Amgen Inc. | Aimovig (Biological) | Travel and Lodging | Cash or cash equivalent | $30.42 | General |
| Category: Neuroscience | ||||||
| 06/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: PRIMARY CARE | ||||||
| 06/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: PRIMARY CARE | ||||||
| 06/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $104.65 | General |
| Category: PRIMARY CARE | ||||||
| 06/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $50.80 | General |
| Category: PRIMARY CARE | ||||||
| 06/01/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: PRIMARY CARE | ||||||
| 06/01/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: PRIMARY CARE | ||||||
| 05/31/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Neuroscience | ||||||
| 05/31/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: Central Nervous System | ||||||
| 05/26/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: PRIMARY CARE | ||||||
| 05/26/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $121.79 | General |
| Category: PRIMARY CARE | ||||||
| 05/26/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Travel and Lodging | Cash or cash equivalent | $66.69 | General |
| Category: PRIMARY CARE | ||||||
| 05/26/2022 | UPSHER-SMITH LABORATORIES LLC | ZEMBRACE SYMTOUCH (Drug), TOSYMRA | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: NEUROLOGY | ||||||
| 05/25/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/25/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: Neuroscience | ||||||
| 05/24/2022 | Amgen Inc. | Aimovig (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Neuroscience | ||||||
| 05/24/2022 | Amgen Inc. | Aimovig (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Neuroscience | ||||||
| 05/24/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 05/24/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $10.34 | General |
| Category: Neuroscience | ||||||
| 05/24/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $1.39 | General |
| Category: Neuroscience | ||||||
| 05/23/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2022 | Banner Life Sciences, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Immune | ||||||
| 05/21/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: PRIMARY CARE | ||||||
| 05/19/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $118.11 | General |
| Category: Neuroscience | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF GALCANEZUMAB IN ADULTS WITH TREATMENT-RESISTANT MIGRAINE - THE CONQUER STUDY | Eli Lilly and Company | $54,726 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 415 | 483 | $99,046 | $29,234 |
| 2021 | 13 | 953 | 1,218 | $275,238 | $89,574 |
| 2020 | 12 | 1,134 | 6,228 | $436,308 | $131,099 |
Total Patients
2,502
Total Services
7,929
Medicare Billing
$249,907
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 189 | $51,597 | $15,418 | 29.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 38 | $13,908 | $4,579 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $17,015 | $4,524 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 37 | $6,882 | $2,025 | 29.4% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2022 | 20 | 48 | $4,464 | $1,221 | 27.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 14 | 14 | $2,072 | $636.02 | 30.7% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2022 | 20 | 20 | $1,860 | $504.92 | 27.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 94 | 96 | $1,248 | $327.14 | 26.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 246 | 342 | $93,366 | $32,180 | 34.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 107 | 107 | $44,405 | $12,704 | 28.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 74 | 86 | $31,476 | $12,188 | 38.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 83 | $15,438 | $5,312 | 34.4% |
| 96139 | Psychological or neuropsychological test administration and scoring by technician, additional 30 minutes | Office | 2021 | 56 | 171 | $15,903 | $4,650 | 29.2% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 50 minutes | Office | 2021 | 22 | 22 | $14,344 | $4,565 | 31.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 26 | 26 | $13,598 | $4,331 | 31.8% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 16 | 16 | $13,483 | $4,074 | 30.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $8,256 | $2,574 | 31.2% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 11 | 19 | $7,543 | $2,003 | 26.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 15 | $5,250 | $1,671 | 31.8% |
| 96138 | Psychological or neuropsychological test administration and scoring by technician, first 30 minutes | Office | 2021 | 57 | 58 | $5,394 | $1,578 | 29.3% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 20 | 20 | $3,701 | $920.80 | 24.9% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 211 | 237 | $3,081 | $822.96 | 26.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 323 | 467 | $127,491 | $36,908 | 28.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 14 | 4,755 | $71,325 | $23,023 | 32.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 152 | 152 | $63,080 | $18,916 | 30.0% |
About Dr. Katherine Standley, DO
Dr. Katherine Standley, DO is a Neurology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2009. The National Provider Identifier (NPI) number assigned to this provider is 1154556181.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Standley, DO has received a total of $1.3M in payments from pharmaceutical and medical device companies, with $97,013 received in 2022. These payments were reported across 2,337 transactions from 60 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.0M).
As a Medicare-enrolled provider, Standley has provided services to 2,502 Medicare beneficiaries, totaling 7,929 services with total Medicare billing of $249,907. Data is available for 3 years (2020–2022), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Tampa, FL
- Active Since 05/20/2009
- Last Updated 06/17/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1154556181
Products in Payments
- Aimovig (Biological) $285,329
- AUBAGIO (Drug) $248,149
- NURTEC ODT (Drug) $162,644
- LEMTRADA (Drug) $78,653
- OCREVUS (Biological) $63,774
- GILENYA (Drug) $63,540
- UBRELVY (Drug) $33,553
- TECFIDERA (Drug) $31,495
- AJOVY (Biological) $29,387
- TYSABRI (Biological) $28,470
- VUMERITY (Drug) $22,323
- EMGALITY (Drug) $19,417
- AJOVY (Drug) $15,477
- REYVOW (Drug) $13,650
- DISEASE STATE (Drug) $3,985
- ZINBRYTA (Biological) $3,722
- Trudhesa (Drug) $1,425
- ZEPOSIA (Drug) $1,358
- BOTOX (Biological) $518.86
- TROKENDI XR (Drug) $416.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Tampa
Derrick Robertson, M.d, M.D
Neurology — Payments: $2.3M
Neurology $2.3M
Selim Benbadis, Md, MD
Neurology — Payments: $2.3M
Neurology $2.3M
Dr. Mark Cascione, M.d, M.D
Neurology — Payments: $1.9M
Neurology $1.9M
Robert Hauser, Md, MD
Neurology — Payments: $1.5M
Neurology $1.5M
David Rose, M.d, M.D
Neurology — Payments: $1.5M
Neurology $1.5M
Dr. Tuan Vu, Md, MD
Neurology — Payments: $1.2M
Neurology $1.2M